BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bussu F, Graziani C, Gallus R, Cittadini A, Galli J, DE Corso E, DI Cintio G, Corbi M, Almadori G, Boninsegna A, Paludetti G, Sgambato A. IFN-γ and other serum cytokines in head and neck squamous cell carcinomas. Acta Otorhinolaryngol Ital 2018;38:94-102. [PMID: 29967556 DOI: 10.14639/0392-100X-1530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Moody L, Crowder SL, Fruge AD, Locher JL, Demark-Wahnefried W, Rogers LQ, Delk-Licata A, Carroll WR, Spencer SA, Black M, Erdman JW Jr, Chen H, Pan YX, Arthur AE. Epigenetic stratification of head and neck cancer survivors reveals differences in lycopene levels, alcohol consumption, and methylation of immune regulatory genes. Clin Epigenetics 2020;12:138. [PMID: 32917280 DOI: 10.1186/s13148-020-00930-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li C, Wu ZH, Yuan K. Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma. Dis Markers 2020;2020:8899337. [PMID: 33133307 DOI: 10.1155/2020/8899337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Anderson K, Ryan N, Alkhimovitch A, Siddiqui A, Oghumu S. Inhibition of PI3K Isoform p110γ Increases Both Anti-Tumor and Immunosuppressive Responses to Aggressive Murine Head and Neck Squamous Cell Carcinoma with Low Immunogenicity. Cancers (Basel) 2021;13:953. [PMID: 33668795 DOI: 10.3390/cancers13050953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bednarz-Misa I, Bromke MA, Krzystek-Korpacka M. Interleukin (IL)-7 Signaling in the Tumor Microenvironment. Adv Exp Med Biol 2021;1290:9-49. [PMID: 33559853 DOI: 10.1007/978-3-030-55617-4_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Astradsson T, Sellberg F, Berglund D, Ehrsson YT, Laurell GFE. Systemic Inflammatory Reaction in Patients With Head and Neck Cancer-An Explorative Study. Front Oncol 2019;9:1177. [PMID: 31750257 DOI: 10.3389/fonc.2019.01177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Pasvenskaite A, Liutkeviciene R, Gedvilaite G, Vilkeviciute A, Liutkevicius V, Uloza V. The Role of IL-9 Polymorphisms and Serum IL-9 Levels in Carcinogenesis and Survival Rate for Laryngeal Squamous Cell Carcinoma. Cells 2021;10:601. [PMID: 33803218 DOI: 10.3390/cells10030601] [Reference Citation Analysis]
7 Agnihotri V, Gupta A, Kumar L, Dey S. Serum sHLA-G: Significant diagnostic biomarker with respect to therapy and immunosuppressive mediators in Head and Neck Squamous Cell Carcinoma. Sci Rep 2020;10:3806. [PMID: 32123232 DOI: 10.1038/s41598-020-60811-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Nisar S, Yousuf P, Masoodi T, Wani NA, Hashem S, Singh M, Sageena G, Mishra D, Kumar R, Haris M, Bhat AA, Macha MA. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment. Int J Mol Sci 2021;22:4584. [PMID: 33925575 DOI: 10.3390/ijms22094584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]